Filing Details

Accession Number:
0001181431-13-059343
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-15 20:55:26
Reporting Period:
2013-11-13
Filing Date:
2013-11-15
Accepted Time:
2013-11-15 20:55:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497253 Organovo Holdings Inc. ONVO Biological Products, (No Disgnostic Substances) (2836) 271488943
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1549671 Eric David 6275 Nancy Ridge Drive, Suite 110
San Diego CA 92121
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-13 16,470 $10.39 731,306 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were acquired pursuant to a cashless exercise of an in-the-money warrant exempt from Section 16(b). The Reporting Person initially acquired the warrant on February 8, 2012.
  2. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.30 to $10.45. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. This number does not include 700,000 shares of common stock underlying outstanding options held by Mr. David; post-transaction Mr. David continues to beneficially own or have a right to acquire 1,431,306 shares of common stock.